CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities:
Net income	$ 17,760	$ 12,945
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses	4,172	3,936
Depreciation and amortization of premises and equipment	1,741	1,746
Loss on disposal of premises and equipment	0	3
Non-cash lease expense	28	0
Cash flows for operating leases	(1,280)	(1,257)
Amortization of mortgage servicing rights	192	178
Net (accretion of discount) amortization of premium on investment securities	(324)	561
Share-based compensation	(205)	148
Net gain on sales of residential mortgage loans	(187)	(217)
Proceeds from sales of loans held for sale	14,454	10,759
Originations of loans held for sale	(11,393)	(9,736)
Equity in (losses) earnings of unconsolidated entities	(2)	80
Net increase in cash surrender value of bank-owned life insurance	(497)	(1,522)
Deferred income tax expense	5,330	2,652
Net tax expense from share-based compensation	69	60
Net change in other assets and liabilities	(9,418)	(3,340)
Net cash provided by operating activities	20,440	16,996
Cash flows from investing activities:
Purchases of investment securities available-for-sale	(40,823)	(32,624)
Proceeds from maturities, prepayments and calls of investment securities available-for-sale	13,902	11,606
Proceeds from maturities, prepayments and calls of investment securities held-to-maturity	8,606	8,827
Net loan payments received	26,860	33,444
Purchases of loan portfolios	(31,440)	0
Purchases of bank-owned life insurance	(133)	0
Net purchases of premises and equipment	(889)	(3,253)
Contributions to unconsolidated entities	(950)	(7,707)
Net purchases of FHLB and FRB stock	(17,234)	(128)
Net cash (used in) provided by investing activities	(42,101)	10,165
Cash flows from financing activities:
Net decrease in deposits	(47,963)	(228,738)
Repayments of long-term debt	(25,000)	0
Cash dividends paid on common stock	(7,327)	(7,033)
Repurchases of common stock and other related costs	(2,094)	(945)
Net cash used in financing activities	(82,384)	(236,716)
Net decrease in cash and cash equivalents	(104,045)	(209,555)
Cash and cash equivalents at beginning of period	380,941	522,437
Cash and cash equivalents at end of period	276,896	312,882
Cash paid during the period for:
Interest expense paid	20,801	26,509
Supplemental disclosure of non-cash information:
Lease liabilities arising from obtaining right-of-use lease assets	0	3,333
Amortization of unrealized losses on investment securities transferred to held-to-maturity at fair value	$ 1,552	$ 1,638

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets, and the amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.

No definition available.